Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/06/2026 | CALL | $26.00 | 11,769 | +1,829 | +18.40% |
| 06/18/2026 | PUT | $26.00 | 4,781 | +1,198 | +33.44% |
| 03/20/2026 | PUT | $25.00 | 31,705 | +1,066 | +3.48% |
| 06/18/2026 | CALL | $31.00 | 1,931 | +963 | +99.48% |
| 01/30/2026 | CALL | $28.00 | 7,425 | +952 | +14.71% |
| 02/06/2026 | CALL | $26.50 | 6,709 | +917 | +15.83% |
| 02/13/2026 | CALL | $28.00 | 672 | -180 | -21.13% |
| 02/06/2026 | CALL | $28.00 | 2,276 | -233 | -9.29% |
| 06/18/2026 | CALL | $30.00 | 49,476 | -370 | -0.74% |
| 01/15/2027 | CALL | $20.00 | 10,814 | -422 | -3.76% |
| 01/30/2026 | PUT | $25.50 | 6,011 | -603 | -9.12% |
| 01/30/2026 | CALL | $26.00 | 17,127 | -3,507 | -17.00% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.02% | 170.64M | 6.14B |
| Vanguard 500 Index Fund | 2.30% | 129.76M | 4.67B |
| Washington Mutual Investors Fund | 1.42% | 80.41M | 2.89B |
| Fidelity 500 Index Fund | 1.09% | 61.54M | 2.21B |
| SPDR S&P 500 ETF Trust | 1.08% | 60.77M | 2.19B |
| American Balanced Fund | 1.00% | 56.61M | 2.04B |
| Income Fund of America Inc | 0.93% | 52.68M | 1.9B |
| iShares Core S&P 500 ETF | 0.89% | 50.1M | 1.8B |
| Vanguard Index-Value Index Fund | 0.86% | 48.51M | 1.75B |
| Vanguard Specialized-Health Care Fund | 0.86% | 48.32M | 1.74B |
This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy?
01/30 11:18 pm
The Motley Fool
Read moreThis Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy?
01/29 09:30 am
The Motley Fool
Read more3 High-Yield Stocks to Buy Hand Over Fist in January
01/29 08:03 am
The Motley Fool
Read moreThis Could Be 1 of the Best Pharmaceutical Stock-Buying Opportunities I've Seen in Years
01/28 08:03 pm
The Motley Fool
Read moreSleeping Bruxism Treatment Market Size to Reach USD 1,132.09 Million by 2033, Driven by Rising Awareness of Sleep Disorders and Oral Health Complications – SNS Insider
01/28 07:00 am
GlobeNewswire Inc.
Read moreAtopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR
01/27 11:00 am
GlobeNewswire Inc.
Read moreWhere Will Eli Lilly Be in 10 Years?
01/27 10:07 am
The Motley Fool
Read moreCogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag
01/26 11:06 am
Benzinga
Read moreThe Best Stocks to Invest $40 in to Start the New Year Off Right
01/24 02:15 pm
The Motley Fool
Read morePfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research
01/23 01:36 pm
Benzinga
Read moreLipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies
01/23 11:00 am
GlobeNewswire Inc.
Read moreFDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer
01/22 01:51 pm
Benzinga
Read morePostpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider
01/22 12:00 pm
GlobeNewswire Inc.
Read moreIs Pfizer an Absurdly Cheap Dividend Stock, or Just a Value Trap?
01/22 07:30 am
The Motley Fool
Read moreNew nanoparticle technology offers hope for hard-to-treat diseases
01/22 12:12 am
GlobeNewswire Inc.
Read moreIs This Dividend King Stock a Buy After a Major Development?
01/21 10:30 pm
The Motley Fool
Read moreHigh Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider
01/21 12:00 pm
GlobeNewswire Inc.
Read moreAmyloidosis Therapeutic Market to Worth Over US$ 6.37 Billion by 2033 | Astute Analytica
01/21 11:54 am
GlobeNewswire Inc.
Read moreJohnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative
01/21 10:43 am
Investing.com
Read more3 No-Brainer Dividend Stocks to Buy Right Now -- Including Pfizer
01/21 07:26 am
The Motley Fool
Read moreU.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships
01/21 05:52 am
GlobeNewswire Inc.
Read moreExecutive Coach Michael King Releases Music Video "Unbreakable Things" on Leadership Identity
01/20 04:29 pm
GlobeNewswire Inc.
Read moreGSK To Acquire RAPT Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough
01/20 06:54 am
Benzinga
Read moreLevicept Announces FDA Acceptance of IND Application for LEVI-04, a Potentially Disease-Modifying Treatment for Osteoarthritis
01/20 05:00 am
GlobeNewswire Inc.
Read moreDown 55%, Should You Buy the Dip on Pfizer?
01/19 04:24 pm
The Motley Fool
Read moreBioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider
01/19 12:00 pm
GlobeNewswire Inc.
Read moreSodium Chloride Injections Market, Global Forecast 2026-2032 - Clinical Practice Migration and Manufacturing Modernization are Driving Innovations
01/19 06:53 am
GlobeNewswire Inc.
Read moreWomen Health & Beauty Supplements Market Analysis and Growth Forecast 2026-2030
01/19 05:56 am
GlobeNewswire Inc.
Read moreAscentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
01/14 09:25 pm
GlobeNewswire Inc.
Read moreWhy Tempus AI Stock Rose Today
01/12 08:07 pm
The Motley Fool
Read morePfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial
01/12 12:58 pm
Benzinga
Read morePrediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026
01/09 10:30 am
The Motley Fool
Read moreMadrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor
01/09 09:00 am
GlobeNewswire Inc.
Read moreMerck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight
01/09 02:52 am
Benzinga
Read moreWant Over $2,000 in Dividends Each Year? Invest $12,000 Each Into These 3 Stocks
01/08 12:26 pm
The Motley Fool
Read moreMotley Fool Money: Stock Market Naughty and Nice List
01/06 01:33 am
The Motley Fool
Read moreThese 3 Stocks Trade at Discounts the Market Won’t Ignore Forever
01/05 01:35 pm
Investing.com
Read more2 Predictions for Pfizer in 2026
01/02 05:30 pm
The Motley Fool
Read morePfizer: Why Wall Street Gave Up—And Why That May Be a Mistake
01/02 12:24 pm
Investing.com
Read moreDrugmakers Plan Fresh Price Hikes On 350 Medicines In 2026
12/31 09:59 am
Benzinga
Read moreCeliac Disease Market Report 2025-2035: Drivers, Challenges, Opportunities, Industry Trends and Case Studies
12/30 11:51 am
GlobeNewswire Inc.
Read more3 Drug Stocks to Buy at a Discount
12/27 05:28 pm
The Motley Fool
Read more3 Superb High-Yield Dividend Stocks With Yields North of 5% That Make for No-Brainer Buys Right Now
12/27 07:30 am
The Motley Fool
Read moreGot $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever
12/24 06:26 pm
The Motley Fool
Read more